Form 4: Core Laboratories Inc. Chairman and CEO Lawrence Bruno Reports Changes in Beneficial Ownership

Lawrence Bruno, Chairman and CEO of Core Laboratories Inc., reports transactions involving common stock and performance shares, resulting in adjustments to his beneficial ownership.

Summary

• On December 31, 2024, Lawrence Bruno, Chairman and CEO of Core Laboratories Inc., reported changes in his beneficial ownership of the company's securities.
• These changes involve the disposition of 43,380 common stock shares at a price of $17.31 and the acquisition of 69,574 common stock shares at $0.
• These transactions resulted in an increase in his direct ownership of common stock from 189,397 to 232,777 shares.
• Additionally, 69,574 performance shares vested on December 31, 2024, as the company finished in the 52nd percentile of return on invested capital among its peer group, satisfying the vesting requirements at 54.6% of the target award level.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports transactions and the vesting of performance shares based on pre-defined criteria. There is no indication of significant positive or negative news.

Positives

• The vesting of performance shares indicates that the company met certain performance criteria related to return on invested capital.
• The increase in direct ownership of common stock could be interpreted as a sign of confidence in the company's future prospects by the CEO.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The vesting of performance shares is tied to the company's performance relative to its peers, reflecting a common practice in executive compensation.

Comparison to Industry Standards

• The vesting of performance shares based on return on invested capital (ROIC) is a common practice among publicly traded companies, particularly in the energy and technology sectors.
• Companies like Schlumberger (SLB) and Halliburton (HAL), which are direct competitors of Core Laboratories, also use similar performance-based compensation structures to align executive incentives with shareholder value.
• The 52nd percentile ROIC performance suggests that Core Laboratories is performing around the median compared to its peers, which could be viewed as average performance.

Stakeholder Impact

• The vesting of performance shares impacts shareholders by aligning executive compensation with company performance.
• Employees may be indirectly affected by the performance-based compensation structure, as it can influence company strategy and priorities.

Key Dates